Association between Immune Checkpoint Inhibitors and Atherosclerotic Cardiovascular Disease Risk: Another Brick in the Wall

Association between Immune Checkpoint Inhibitors and Atherosclerotic Cardiovascular Disease Risk: Another Brick in the Wall

In recent years, immune checkpoint inhibitors have significantly changed the field of oncology, emerging as first-line treatment, either alone or in combination with other regimens, for numerous malignancies, improving overall survival and progression-free survival in these patients. However, immune...

Full description

Bibliographic Details
Main Authors: Linda Piras, Michela Zuccanti, Paola Russo, Francesca Riccio, Antonio Agresti, Camilla Lustri, Domenico Dardani, Armando Ferrera, Vincenzo Fiorentini, Giuliano Tocci, Giacomo Tini Melato, Massimo Volpe, Emanuele Barbato, Allegra Battistoni
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:International Journal of Molecular Sciences
Subjects:
immune checkpoint inhibitors
cardiac event
cardiotoxicity
atherosclerosis
atherosclerotic cardiovascular events
inflammation
Online Access:https://www.mdpi.com/1422-0067/25/5/2502

Internet

https://www.mdpi.com/1422-0067/25/5/2502

Similar Items